Abstract:What is known and objective Adverse drug reaction (ADR) reporting is generally of poor quality, which may delay post-marketing regulatory actions. Here, we evaluated the quality of ADR reporting at our institution and examined the roles of clinical pharmacists in this process. Methods We retrospectively reviewed ADR reports at our hospital between 2017 and 2019 to assess the number, source, drugs, and routes of administration. The quality assessment of ADR case reports form issued by the China Adverse Drug Reaction Monitoring Centre was used to assess the quality of ADR reports. Quality scores of ADR reports from pharmacists and nonpharmacists were assessed before and after review by clinical pharmacists. Results and discussion Reports of adverse drug reaction reporting by healthcare professionals increased annually, with 59, 77 and 82 reports submitted in 2017, 2018 and 2019, respectively. The numbers of new or serious ADR reports by healthcare professionals in 2017, 2018, and 2019 were 5 (8.47%), 77 (11.69%) and 82 (10.98%), respectively. New or serious ADR reports accounted for approximately 10% (23/218) of all reported cases, and more than 70% (158/218) of the reports were from pharmacists. Systemic administration accounted for more than 80% (233/265) of adverse reactions, whereas ADRs due to topical drug use were rarely reported. The drugs that reportedly triggered ADRs were mainly antibacterial and patented Chinese medicines and accounted for more than half of all reported cases. The scores of ADR reports from pharmacists and nonpharmacists before modification by clinical pharmacists were 86.69 +/- 8.12 and 68.36 +/- 5.94, respectively, and the scores of ADR reports from pharmacists and nonpharmacists after modification by clinical pharmacists were 91.14 +/- 6.64 and 90.02 +/- 5.63, respectively. What is new and conclusion In a real-world setting, pharmacists are commonly responsible for most ADR reports. The quality of ADR reports from pharmacists and nonpharmacists before review did not reach the standard of excellence. An audit of clinical pharmacists may improve the overall quality of ADR reports. However, under-reporting of adverse reactions still occurs.

Quality of Adverse Drug Reaction Reports Submitted by Health Care Professionals in Xi'an

Quality Analysis of the Adverse Drug Reactions Reports from Shanghai Healthcare Professionals

The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China.

The Quality Analysis of Adverse Drug Reaction Reports in Shanghai During 2003-2007

The Quality of Spontaneous Adverse Drug Reaction Reports in China: A Descriptive Study.

Adverse Drug Reaction Reporting Quality among Different Health Professionals and the Contribution of Clinical Pharmacists: A Pilot Study

Retrospective Analysis of ADR Cases Reported in 2006 in Shenzhen

Effect of Medical Background Differences on Reports of Adverse Drug Reactions

Analysis and Evaluation of the Adverse Drug Reaction Reports from the Drug Manufacturers in Shaanxi Province Between 2012 and 2014

Adverse Drug Reaction Reporting in Institutions Across Six Chinese Provinces: A Cross-sectional Study.

Investigation on the ADR Reporting Entities in Shaanxi and Sichuan Province

Analysis on 311 Cases of Adverse Drug Reaction Report in Our Hospital During 2002～2005

Hospital Pharmacists' Knowledge and Opinions Regarding Adverse Drug Reaction Reporting in Northern China.

Investigation on Work State of Adverse Drug Reaction Reporting in Some West Provinces

Study on the Adverse Drug Reaction Reporting Entities in Jiangsu Province and Guangdong Province

Reporting Patterns of Adverse Drug Reactions over Recent Years in China: Analysis from Publications

The Knowledge and Reporting of Adverse Drug Reactions in Healthcare Professionals and the Public in China

An Analysis of 139 Reports of ADR

Survey of Basic Knowledge and Attitude to Adverse Drug Reaction Reports Among Healthcare Professionals in Anhui Province

Study on 990 Cases of Adverse Drug Reaction

Study on the Knowledge and Attitude to Adverse Drug Reactions Reporting among Healthcare Professionals in Wuhan City